Package 61825-302-60
Brand: orphengesic forte
Generic: orphenadrine citrate, aspirin and caffeinePackage Facts
Identity
Package NDC
61825-302-60
Digits Only
6182530260
Product NDC
61825-302
Description
60 TABLET in 1 BOTTLE, PLASTIC (61825-302-60)
Marketing
Marketing Status
Brand
orphengesic forte
Generic
orphenadrine citrate, aspirin and caffeine
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "414bbb21-3b1f-9924-e063-6294a90a8964", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "upc": ["0361825302602"], "unii": ["R16CO5Y76E", "3G6A5W338E", "X0A40N8I4S"], "rxcui": ["994535", "994539"], "spl_set_id": ["5bc485db-9d96-4291-aaa3-2a96ebf3098a"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Galt Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE, PLASTIC (61825-302-60)", "package_ndc": "61825-302-60", "marketing_start_date": "20200608"}], "brand_name": "ORPHENGESIC FORTE", "product_id": "61825-302_414bbb21-3b1f-9924-e063-6294a90a8964", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Centrally-mediated Muscle Relaxation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Muscle Relaxant [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "61825-302", "generic_name": "Orphenadrine Citrate, Aspirin and Caffeine", "labeler_name": "Galt Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ORPHENGESIC FORTE", "active_ingredients": [{"name": "ASPIRIN", "strength": "770 mg/1"}, {"name": "CAFFEINE", "strength": "60 mg/1"}, {"name": "ORPHENADRINE CITRATE", "strength": "50 mg/1"}], "application_number": "ANDA075141", "marketing_category": "ANDA", "marketing_start_date": "20200608", "listing_expiration_date": "20261231"}